Demystifying Ocular Syphilis – A Major Review
Khushboo Chauhan(Chaudhary Charan Singh Haryana Agricultural University), Mudit Tyagi(L V Prasad Eye Institute), Joveeta Joseph(L V Prasad Eye Institute), Alex Fonollosa(University of the Basque Country), João M. Furtado(University of Washington), Supawat Trepatchayakorn(Moorfields Eye Hospital), Justine R. Smith(Flinders University), Edward L. Randerson(Froedtert Hospital), Debra A. Goldstein(Northwestern University), Nivedita Nair(Sankara Nethralaya), Joseba Artaraz(University of the Basque Country), Abdelrahman M. Elhusseiny(Boston Children's Hospital), Lena Giralt(University of the Basque Country), Mark Westcott(Barts Health NHS Trust), Sridharan Sudharshan(Sankara Nethralaya), Carlos Pavésio(Moorfields Eye Hospital NHS Foundation Trust), Arshee S. Ahmed(Sankara Nethralaya), Ahmed B. Sallam(University of Arkansas for Medical Sciences)
Cited by 24
Related Papers
Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016
|The Lancet|2018|460
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
|Lara D. Veeken|2008|149
British Ocular Syphilis Study (BOSS): 2-Year National Surveillance Study of Intraocular Inflammation Secondary to Ocular Syphilis
|Investigative Ophthalmology & Visual Science|2014|138
Viral posterior uveitis
|Survey of Ophthalmology|2016|126